JPH0411535B2 - - Google Patents

Info

Publication number
JPH0411535B2
JPH0411535B2 JP60169771A JP16977185A JPH0411535B2 JP H0411535 B2 JPH0411535 B2 JP H0411535B2 JP 60169771 A JP60169771 A JP 60169771A JP 16977185 A JP16977185 A JP 16977185A JP H0411535 B2 JPH0411535 B2 JP H0411535B2
Authority
JP
Japan
Prior art keywords
substance
culture
strain
added
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60169771A
Other languages
Japanese (ja)
Other versions
JPS6230735A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP16977185A priority Critical patent/JPS6230735A/en
Publication of JPS6230735A publication Critical patent/JPS6230735A/en
Publication of JPH0411535B2 publication Critical patent/JPH0411535B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

産業上の利用分野 本発明は、新規な抗生物質SF−2418物質及び
その製造法に関するものである。 従来の技術及び発明が解決しようとする問題点 SF−2418物質に類似する既知物質としては、
ピロキノン(ネイチヤー第199巻、285−286ペー
ジ、1963年)及びハロキノン(ジヤーナル・オ
ブ・アンチバイオテイツクス、第34巻、1531−
1543ページ、1981年)が挙げられるが、元素分析
値、分子量及び分子式が異なることから、これら
の既知物質とは明瞭に区別される。従つてSF−
2418物質は新規な物質と判定された。 問題を解決するための手段 本発明者らは鶏マイコプラズマ及び豚トレポネ
マ菌に抗菌活性を有する新規かつ有用な抗生物質
を探索した結果、ストレプトミセス属に属する菌
株の培養物中に新規抗生物質SF−2418物質が生
産されていることを見いだし、その有効物質を培
養物中から純粋に単離し、その化学構造を決定
し、生物活性を検討することにより、本発明を完
成させた。すなわち、本発明に使用されるSF−
2418物質生産菌の一例としては、本発明者らによ
り京都市の土壌より新たに分離されたSF−2418
株がある。SF−2418株の菌学的性状は次の通り
である。 形態 基生菌糸はよく伸長分岐し、通常の条件下で
は分断しない。スターチ寒天、オートミール寒
天培地等で気菌糸を良好に着生し、胞子形成も
豊富である。気菌糸の分岐は単純分岐で車軸分
岐は見られない。気菌糸先端の胞子連鎖は直鎖
状、ループ状あるいはフツク状で、螺旋状も認
められる。胞子の運動性は観察されない。胞子
のう、菌核などの特殊構造は観察されない。電
子顕微鏡による観察では、胞子は卵型ないし楕
円型で、大きさは0.5乃至0.7×0.6乃至1.0μ、表
面構造は毛状(hairy)である。胞子は通常10
乃至50個程度連鎖する。 各種培地上での生育状態 SF−2418株の各種寒天培地上での生育状態
は次表に示す通りである。培養は28℃で行い、
観察は14乃至21日培養後に行つた。気菌糸の色
の( )内に示す記号はコンテイナー・コーポ
レーシヨン・オブ・アメリカ社製のカラー・ハ
ーモニー・マニユアルを用いた。
INDUSTRIAL APPLICATION FIELD The present invention relates to a novel antibiotic SF-2418 substance and a method for producing the same. Conventional techniques and problems to be solved by the invention Known substances similar to SF-2418 substance include:
Pyroquinone (Nature Vol. 199, pp. 285-286, 1963) and Haloquinone (Journal of Antibiotics, Vol. 34, 1531-
1543 pages, 1981), but it is clearly distinguished from these known substances because the elemental analysis values, molecular weight, and molecular formula are different. Therefore, SF−
2418 substances were determined to be new substances. Means for Solving the Problem The present inventors searched for a new and useful antibiotic having antibacterial activity against chicken Mycoplasma and porcine Treponema, and found that the novel antibiotic SF- The present invention was completed by discovering that 2418 substances were produced, isolating the effective substances from culture, determining their chemical structures, and examining their biological activities. That is, SF- used in the present invention
An example of a 2418 substance-producing bacterium is SF-2418, which was newly isolated from soil in Kyoto City by the present inventors.
There are stocks. The mycological properties of SF-2418 strain are as follows. Morphology The basal hyphae are well elongated and branched, and do not divide under normal conditions. It adheres well to aerial mycelia on starch agar, oatmeal agar, etc., and forms abundant spores. The branching of aerial hyphae is simple, and no axle branching is observed. The spore chain at the tip of the aerial hyphae is linear, loop-shaped, or hook-shaped, and spiral shapes are also observed. No spore motility is observed. Special structures such as sporangia and sclerotia are not observed. When observed using an electron microscope, the spores are oval or oval in shape, 0.5 to 0.7 x 0.6 to 1.0 μm in size, and have a hairy surface structure. Spores are usually 10
About 50 pieces are chained together. Growth status on various media The growth status of SF-2418 strain on various agar media is as shown in the following table. Cultivation was carried out at 28°C.
Observations were made after 14 to 21 days of culture. For the symbols shown in parentheses for the color of aerial mycelia, the Color Harmony Manual manufactured by Container Corporation of America was used.

【表】 生理的性質 (1) 生育温度範囲:イースト麦芽寒天培地にお
いて15乃至42℃の温度範囲で生育し、26乃至
32℃において良好に生育する。 (2) ゼラチンの液化:陽性 (3) スターチの加水分解:陽性 (4) 硝酸塩の還元:陰性 (5) 脱脂乳に対する作用:ペプトン化、凝固と
もに陰性 (6) 耐塩製:3%食塩添加では生育するが、4
%以上では生育しない。 (7) メラニン様色素の生成:陰性 炭素源の利用法 (1) 利用する:D−グルコース、D−フラクト
ース、D−キシロース (2) 利用が疑わしい:L−アラビノース (3) 利用しない:D−マンニトール、i−イノ
シトール、ラフイノース、L−ラムノース 菌体分析 全菌体の加水分解中のジアミノピメリン酸は
LL型であつた。 以上の菌学的性状から、SF−2418株は、放
線菌の中でストレプトミセス属に属する菌株で
ある。本発明者らはSF−2418株をストレプト
ミセス・エスピー・SF−2418(Streptomyces
sp.SF−2418)と称することとした。なお、本
菌株は微生物工業技術研究所に微工研菌寄第
8156号(FERM P−8156)として寄託されて
いる。 SF−2418株は他の放線菌の場合にみられる
ように、その性状が変化しやすい。例えばSF
−2418株の、またはこの株に由来する突然変異
株(自然発生または誘発性)形質接合体または
遺伝子組換え体であつても、SF−2418物質を
生産するものは総て本発明に使用できる。 本発明の方法では、前記の菌を通常の微生物
が利用しうる栄養物を含有する培地で培養す
る。栄養源としては、従来放線菌の培養に利用
されている公知のものが使用できる。例えば、
炭素源としてグルコース、水飴、デキストリ
ン、澱粉、糖蜜、動、植物油等を使用できる。
また、窒素源として大豆粉、小麦はい芽、コー
ンステイープリカー、綿実粕、肉エキス、酵母
エキス、硫酸アンモニウム、硝酸ソーダ、尿素
等を利用できる。その他、必要に応じてナトリ
ウム、カリウム、マグネシウム、コバルト、塩
素、燐酸、硫酸及びその他のイオンを生成でき
る無機塩類を添加するのが有効である。また、
菌の発育を助け、SF−2418物質の生産を促進
するような有機及び無機物を適当に添加するこ
とができる。培養法としては、好気的条件下で
の培養法、特に深部培養法が最も適している。
培養に適当な温度は15乃至37℃であるが、多く
の場合26乃至32℃付近で培養する。SF−2418
物質の生産は培地や培養条件によつて異なる
が、振盪培養、タンク培養とも通常2乃至10日
間でその蓄積が最高に達する。 このように生産されるSF−2418物質は、後
記の理化学的性状を有するので、その性状に従
つて培養物から抽出、精製することが可能であ
るが、特に以下の方法により効率的に抽出、精
製することができる。 即ち、有効成分を含む培養物に酢酸エチル等
の水と自由に混和しない有機溶媒を加えて撹拌
抽出する。あるいは培養物から固形物を濾別し
た濾液に酢酸エチル等の水と自由に混和しない
溶媒を加えて撹拌抽出する。一方、固形物はア
セトン等の水と自由に混和する溶媒を加えて撹
拌し、固形物から有効成分を抽出し、有機溶媒
を留去した後、酢酸エチル等の水と自由に混和
しない有機溶媒で有効成分を抽出する。 このようにして得られた有効成分を含む抽出
液の溶媒を留去して得た油状物質にn−ヘキサ
ンを加えて沈澱を得る。その沈澱物をシリカゲ
ルクロマトグラフイーにかけSF−2418物質を
単離する。単離されたSF−2418物質をベンゼ
ン、n−ヘキサン等の溶媒系を用いて結晶化
し、SF−2418物質の結晶を得る。 SF−2418物質の検定に当つては、マイコプ
ラズマ・ガリセプチカム(Mycoplasma
gallisepticum)を検定菌とする生物学的検定
法を用いる。 SF−2418物質の理化学的性状は下記の通り
である。 (1) 元素分析値:炭素70.29%、水素5.03%、
酸素24.68% (2) 分子式及び分子量:C19H16O5;324(FD−
MS) (3) 融点:195℃ (4) 紫外線吸収スペクトル:メタノール溶液
中、アルカリ性メタノール溶液中及び酸性メ
タノール溶液中の紫外線吸収スペクトルを第
1図に示した通りで、下記の極大吸収nm
(E)を示す。 メタノール溶液中: 227nm(23,300) 255nm肩(10,700) 275nm肩(11,000) 283nm(11,700) 392nm(2,900) 502nm(3,900) アルカリ性メタノール溶液中: 220nm(31,400) 290nm肩(8,100) 460nm肩(3,900) 573nm(7,400) 酸性メタノール溶液中: 227nm(24,800) 255nm肩(11,300) 275nm肩(12,000) 283nm(12,500) 395nm(3,000) 504nm(3,900) (5) 赤外部吸収スペクトル:第2図に示す通り
である。 (6) 溶解性:アセトン、ベンゼン、クロロフオ
ルムに溶け、水3メタノール、n−ヘキサン
に難溶または不溶である。 (7) 呈色反応:硫酸中、酢酸マグネシウム中及
びメタノール中で青色を呈する。 (8) 薄層クロマトグラフイーのRf値:シリカ
ゲル60F254(メルク社製)の薄層上で下記の
溶媒で展開するときのRf値は次の通りであ
る。 ベンゼン:アセトン=50:1 Rf0.33 トルエン:酢酸エチル=10:1 Rf0.47 トルエン:アセトン=40:1 Rf0.40 (9) 中性、酸性、塩基性の区別:酸性 (10) 物質の色及び外観:褐色針状結晶 (11) 水素核核磁気共鳴スペクトル:第3図に
示す通りである。 (12) 化学構造式: 実施例 (1) 培養 種培地としてスターチ2.0%、グルコース1.0
%、小麦はい芽0.6%、ポリペプトン0.5%、粉
末酵母エキス0.3%、大豆粉0.2%、炭酸カルシ
ウム0.1%を含む培地を用いた。また生産培地
としてグルコース2.5%、綿実油0.5%、小麦は
い芽1.2%、コーンステイープリカー1.0%、炭
酸カルシウム0.3%、硫酸マグネシウム0.1%、
塩化コバルト0.001%を含む培地を用いた。な
お、滅菌前にPH7.0に調整し使用した。 上記種培地20mlを分注した100ml容三角フラ
スコを120℃でストレプトミセス・エスピー・
SF−2418(微工研菌寄第8156号)の斜面培養の
1白金耳を接種し、28℃で4日間振盪培養し、
第一種培養液とした。次いで、種培地80mlずつ
を分注した500ml容三角フラスコ4本を120℃、
30分間滅菌し、上記第一種培養液を4ずつ接
種し、28℃で2日間振盪培養し第二種培養液と
した。次いで、種培地1mlずつ分注した5容
三角フラスコ4本を120℃、30分間滅菌し、上
記第二種培養液を80mlずつ接種し、28℃で1日
間振盪培養し、これを第三種培養液とした。あ
らかじめ120℃で30分間滅菌した30の生産培
地を含む50容ジヤーフアーメンター4基に第
三種培養液を各1ずつ接種し、28℃で5日
間、通気(35/分)、撹拌(初期200rpm、41
時間以降300rpm)培養した。 (2) 単離 培養終了後、濾過助剤として珪藻土を加えて
濾過し、得られた菌体に50%アセトン水72を
加えて有効成分を抽出し、菌体を濾別した。次
いで、菌体抽出液を減圧下で濃縮してアセトン
を留去し、得られた濃縮液8.5に酢酸エチル
8.5を加えて振盪し、有効成分を抽出した。
得られた酢酸エチル抽出液8.0を減圧下で濃
縮して油状物質を得た。この油状物質にn−ヘ
キサンを加え、生じた沈澱を濾取して粗物質
2.8gを得た。この粗物質をトルエンに溶解し、
シリカゲルC−200(和光純薬工業社製)300ml
のカラムにかけ、トルエン−酢酸エチル混合液
で分画した。活性画分注のSF−2418物質はト
ルエン−酢酸エチル(10:1)混液を展開溶媒
とするシリカゲル薄層(キーゼルゲル60F254,
571;メルク社製)クロマトグラフイーを行い、
リンモリブデン酸に浸漬した後、加熱すること
によりRf0.47(赤紫色)に検出された。上記活
性画分を合わせて減圧下で濃縮乾固し、220mg
の粗粉末を得た。この粗粉末をベンゼンに溶解
し、n−ヘキサンを加えて結晶化してSF−
2418物質の褐色針状結晶190mgを得た。 発明の効果 SF−2148物質の各種微生物に対する最低発育
阻止濃度は第1表に示したとおりで、マイコプラ
ズマ、トレポネマに特に有効である。
[Table] Physiological properties (1) Growth temperature range: Grows in the temperature range of 15 to 42℃ on yeast malt agar medium, and
Grows well at 32℃. (2) Liquefaction of gelatin: Positive (3) Hydrolysis of starch: Positive (4) Reduction of nitrate: Negative (5) Effect on skim milk: Both peptonization and coagulation are negative (6) Salt-resistant product: 3% salt added Although it grows, 4
It will not grow above %. (7) Production of melanin-like pigment: negative How to use carbon sources (1) Used: D-glucose, D-fructose, D-xylose (2) Use is questionable: L-arabinose (3) Not used: D- Mannitol, i-inositol, raffinose, L-rhamnose Bacterial cell analysis Diaminopimelic acid during hydrolysis of whole bacterial cells
It was type LL. Based on the above mycological properties, strain SF-2418 is a strain belonging to the genus Streptomyces among actinomycetes. The present inventors used the SF-2418 strain as Streptomyces sp.
sp.SF-2418). This strain has been donated to the Institute of Microbial Technology.
It has been deposited as No. 8156 (FERM P-8156). The SF-2418 strain is susceptible to changes in its properties, as is the case with other actinomycetes. For example, SF
-2418 strain or a mutant strain (naturally occurring or induced) derived from this strain, whether it is a transconjugant or a genetically recombinant strain, any one that produces the SF-2418 substance can be used in the present invention. . In the method of the present invention, the above bacteria are cultured in a medium containing nutrients that can be used by common microorganisms. As the nutrient source, known nutrient sources conventionally used for culturing actinomycetes can be used. for example,
Glucose, starch syrup, dextrin, starch, molasses, animal and vegetable oils, etc. can be used as carbon sources.
In addition, soybean flour, wheat germ, cornstarch liquor, cottonseed meal, meat extract, yeast extract, ammonium sulfate, sodium nitrate, urea, etc. can be used as nitrogen sources. In addition, it is effective to add, if necessary, inorganic salts capable of producing sodium, potassium, magnesium, cobalt, chlorine, phosphoric acid, sulfuric acid, and other ions. Also,
Organic and inorganic substances that aid the growth of bacteria and promote the production of SF-2418 substances can be added as appropriate. The most suitable culture method is a culture method under aerobic conditions, especially a deep culture method.
The appropriate temperature for culturing is 15 to 37°C, but in most cases it is cultured at around 26 to 32°C. SF−2418
Production of the substance varies depending on the medium and culture conditions, but the accumulation usually reaches its maximum within 2 to 10 days in both shaking culture and tank culture. The SF-2418 substance produced in this way has the physical and chemical properties described below, so it can be extracted and purified from the culture according to its properties, but in particular, it can be efficiently extracted and purified by the following method. Can be purified. That is, an organic solvent that is not freely miscible with water, such as ethyl acetate, is added to the culture containing the active ingredient, and the mixture is stirred and extracted. Alternatively, a solvent that is not freely miscible with water, such as ethyl acetate, is added to the filtrate obtained by filtering solid matter from the culture, and the mixture is stirred and extracted. On the other hand, for solids, a solvent that is freely miscible with water such as acetone is added and stirred, the active ingredients are extracted from the solids, and the organic solvent is distilled off. Extract the active ingredients. The solvent of the extract containing the active ingredients thus obtained is distilled off, and n-hexane is added to the obtained oily substance to obtain a precipitate. The precipitate is subjected to silica gel chromatography to isolate SF-2418 material. The isolated SF-2418 substance is crystallized using a solvent system such as benzene and n-hexane to obtain crystals of SF-2418 substance. When testing the SF-2418 substance, Mycoplasma gallisepticum (Mycoplasma gallisepticum)
A biological assay method using M. gallisepticum as the test bacterium is used. The physical and chemical properties of SF-2418 substance are as follows. (1) Elemental analysis values: carbon 70.29%, hydrogen 5.03%,
Oxygen 24.68% (2) Molecular formula and molecular weight: C 19 H 16 O 5 ; 324 (FD−
MS) (3) Melting point: 195℃ (4) Ultraviolet absorption spectra: The ultraviolet absorption spectra in methanol solution, alkaline methanol solution, and acidic methanol solution are shown in Figure 1, and the maximum absorption nm is as follows.
(E) is shown. In methanol solution: 227 nm (23,300) 255 nm shoulder (10,700) 275 nm shoulder (11,000) 283 nm (11,700) 392 nm (2,900) 502 nm (3,900) In alkaline methanol solution: 220 nm (31 ,400) 290nm shoulder (8,100) 460nm shoulder (3,900) 573nm (7,400) In acidic methanol solution: 227nm (24,800) 255nm shoulder (11,300) 275nm shoulder (12,000) 283nm ( 12,500) 395nm (3,000) 504nm (3,900) (5) Infrared absorption spectrum: As shown in Figure 2. (6) Solubility: Soluble in acetone, benzene, and chloroform, poorly soluble or insoluble in water, methanol, and n-hexane. (7) Color reaction: Appears blue in sulfuric acid, magnesium acetate, and methanol. (8) Rf value of thin layer chromatography: The Rf value when developed with the following solvent on a thin layer of silica gel 60F254 (manufactured by Merck & Co.) is as follows. Benzene: Acetone = 50:1 Rf0.33 Toluene: Ethyl acetate = 10:1 Rf0.47 Toluene: Acetone = 40:1 Rf0.40 (9) Distinction between neutral, acidic, and basic: acidic (10) Color and appearance: Brown needle-like crystals (11) Hydrogen nuclear magnetic resonance spectrum: As shown in Figure 3. (12) Chemical structural formula: Example (1) Culture Starch 2.0%, glucose 1.0% as seed medium
%, wheat embryo 0.6%, polypeptone 0.5%, powdered yeast extract 0.3%, soybean flour 0.2%, and calcium carbonate 0.1%. In addition, production media include glucose 2.5%, cottonseed oil 0.5%, wheat embryo 1.2%, corn staple liquor 1.0%, calcium carbonate 0.3%, magnesium sulfate 0.1%,
A medium containing 0.001% cobalt chloride was used. The pH was adjusted to 7.0 before sterilization. Streptomyces sp.
One platinum loop of slant culture of SF-2418 (Feikoken Bibori No. 8156) was inoculated and cultured with shaking at 28°C for 4 days.
This was used as the first type culture solution. Next, four 500 ml Erlenmeyer flasks containing 80 ml of the seed medium were heated at 120°C.
After sterilization for 30 minutes, the above-mentioned first type culture solution was inoculated in four batches, and cultured with shaking at 28°C for 2 days to obtain a second type culture solution. Next, four 5-volume Erlenmeyer flasks into which 1 ml of the seed medium was dispensed were sterilized at 120°C for 30 minutes, and 80 ml each of the above second type culture was inoculated, cultured with shaking at 28°C for 1 day, and this was used as the third type. It was used as a culture solution. Four 50-volume jar fermenters containing 30 production media previously sterilized at 120°C for 30 minutes were inoculated with one third type culture solution each, and incubated at 28°C for 5 days with aeration (35/min) and stirring ( Initial 200rpm, 41
300 rpm). (2) Isolation After completion of the culture, diatomaceous earth was added as a filter aid and filtered, 50% acetone water 72 was added to the obtained bacterial cells to extract the active ingredient, and the bacterial cells were separated by filtration. Next, the bacterial cell extract was concentrated under reduced pressure to remove acetone, and ethyl acetate was added to the resulting concentrated solution (8.5%).
8.5 was added and shaken to extract the active ingredient.
The obtained ethyl acetate extract (8.0%) was concentrated under reduced pressure to obtain an oily substance. Add n-hexane to this oily substance, collect the resulting precipitate by filtration, and obtain the crude substance.
2.8g was obtained. Dissolve this crude material in toluene,
Silica gel C-200 (manufactured by Wako Pure Chemical Industries, Ltd.) 300ml
column and fractionated with a toluene-ethyl acetate mixture. SF-2418 substance for active fraction dispensing was prepared using a thin layer of silica gel (Kieselgel 60F254,
571; Merck & Co.) chromatography was performed,
After immersing in phosphomolybdic acid and heating, it was detected as Rf0.47 (purple red). The above active fractions were combined and concentrated to dryness under reduced pressure to yield 220 mg.
A coarse powder was obtained. This crude powder was dissolved in benzene, and n-hexane was added to crystallize the SF-
190 mg of brown needle-like crystals of substance 2418 were obtained. Effects of the Invention The minimum inhibitory concentration of the SF-2148 substance against various microorganisms is shown in Table 1, and it is particularly effective against Mycoplasma and Treponema.

【表】【table】

【表】 ミクロコッカス・ルテウス* 〓0.025
(Micrococcus luteus)
バチウス・ブレビス* 0.05
(Bacillus brevis)
[Table] Micrococcus luteus * 〓0.025
(Micrococcus luteus)
Batius brevis* 0.05
(Bacillus brevis)

Claims (1)

【特許請求の範囲】 1 下記の化学構造式を有するSF−2418物質。 2 ストレプトミセス属に属する抗生物質SF−
2418物質生産菌を培地に培養し、培養物から下記
に示した化学構造式を有するSF−2418物質を単
離することを特徴とする新抗生物質SF−2418物
質の製造法。
[Claims] 1. SF-2418 substance having the following chemical structural formula. 2 Antibiotic SF- belonging to the genus Streptomyces
A method for producing a new antibiotic SF-2418 substance, which comprises culturing a 2418 substance-producing bacterium in a medium and isolating an SF-2418 substance having the chemical structural formula shown below from the culture.
JP16977185A 1985-08-02 1985-08-02 Novel antibiotic substance sf-2418 and production thereof Granted JPS6230735A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16977185A JPS6230735A (en) 1985-08-02 1985-08-02 Novel antibiotic substance sf-2418 and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16977185A JPS6230735A (en) 1985-08-02 1985-08-02 Novel antibiotic substance sf-2418 and production thereof

Publications (2)

Publication Number Publication Date
JPS6230735A JPS6230735A (en) 1987-02-09
JPH0411535B2 true JPH0411535B2 (en) 1992-02-28

Family

ID=15892553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16977185A Granted JPS6230735A (en) 1985-08-02 1985-08-02 Novel antibiotic substance sf-2418 and production thereof

Country Status (1)

Country Link
JP (1) JPS6230735A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010110216A (en) * 2007-02-20 2010-05-20 Ajinomoto Co Inc Method for producing l-amino acid or nucleic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF ANTIBIOTICS=1981 *

Also Published As

Publication number Publication date
JPS6230735A (en) 1987-02-09

Similar Documents

Publication Publication Date Title
JP2993767B2 (en) FO-1289A substance and method for producing the same
JPH10130269A (en) Carboline derivative
JPH0411535B2 (en)
JPH0625095B2 (en) Antibiotic SF-2415 substance and its production method
JPS63154695A (en) Novel antibiotic substance sf2446 and production thereof
JP3380595B2 (en) Novel antibiotics SF2741A and SF2741B and their production
JPH06184126A (en) Cyclic depsipeptide and its production
RU2032744C1 (en) Strain streptomyces sp - a producer of rifamycin oxidase and a method of rifamycin oxidase preparing
JPH05168488A (en) Production of macrolide antibiotic
JPS59170092A (en) Novel antibiotic, ss8201d and its preparation
JPH0398591A (en) New antibiotic substance having antitumor activity and production thereof
JPH05380B2 (en)
JPS63246388A (en) Antibiotic rs-44b and manufacture
JPS6348284A (en) Novel antibiotic yp-02908l-a and production thereof
JPS63192792A (en) Novel antibiotic sf 2487 substance and production thereof
JPH05207894A (en) Production of macrolide antibiotic
JPS62186787A (en) Novel microorganism
JPH0417199B2 (en)
JPH02191291A (en) Antibiotic ko-3988a and ko-3988b and production thereof
JPS63139190A (en) Antibiotic rs-1223 and its production
JPH0422917B2 (en)
JPS63280073A (en) Novel antibiotic yp-02978l-c and production thereof
JPS5945894A (en) Preparation of coenzyme q10
JPH0398594A (en) New bioactive substance om-6519 and production thereof
JPS6255090A (en) Novel antibiotic substance sf-2392 and production thereof